PHOENIX — As rising drug prices continue to crush patients and the window for Congress to act closes, Patients For Affordable Drugs Now expanded its multi-million dollar campaign into Arizona to ask Sen. Martha McSally to support a key bill in the Senate that would protect Americans from unjustified drug price hikes.
Watch the ad campaign video, “Ashley.”
Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
“President Trump supports the Senate bill, and now, we’re asking Senator McSally to join in calling for a vote on this important legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Patients are asking her to stand with us — not Big Pharma.”
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
DENVER — As rising drug prices continue to crush patients and the window for Congress to act closes, Patients For Affordable Drugs Now expanded its multi-million dollar campaign into Colorado to ask Sen. Cory Gardner to support a key bill in the Senate that would protect Americans from unjustified drug price hikes.
Watch the ad campaign video, “Ashley.”
Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
“President Trump supports the Senate bill, and now, we’re asking Senator Gardner to join in calling for a vote on this important legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Patients are asking him to stand with us — not Big Pharma.”
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
CHARLESTON — Big Pharma is furiously lobbying Washington to protect its profits, but Sen. Shelley Moore Capito is fighting for patients as she works to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a campaign to thank Sen. Capito for her leadership in the fight to lower drug prices and encourage her to support a key bill in the Senate that would protect Americans from unjustified drug price hikes.
Watch the ad campaign video, “Ashley.”
Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
“President Trump supports the Senate bill, and now we’re asking Senator Capito to cosponsor this important bipartisan legislation,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Senator Capito has supported the CREATES Act, which would curtail anticompetitive practices, and has spoken out against high drug prices. Now we are asking her to stand with patients in support of the Senate bill to stop Big Pharma price gouging.”
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma’s profits high and patients’ costs skyrocketing.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
JEFFERSON CITY — Big Pharma is furiously lobbying Washington to protect its profits, but Sen. Josh Hawley is fighting for patients as he works to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a campaign to thank Sen. Hawley for his leadership in the fight to lower drug prices and to encourage him to support a key bill in the Senate that would protect Americans from unjustified drug price hikes.
Watch the ad campaign video, “Ashley.”
Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
“Senator Hawley has supported legislation to lower drug prices since he arrived in Washington, like the Transparent Drug Pricing Act. He’s also asked outstanding questions in Judiciary hearings,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “President Trump supports the bipartisan Senate bill, and now we’re asking Senator Hawley to join in cosponsoring it. And we want him to know that patients will have his back.”
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
JUNEAU — Big Pharma is furiously lobbying Washington to protect its profits, but Sen. Lisa Murkowski is fighting for patients as she works to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a campaign to thank Sen. Murkowski for her leadership in the fight to lower drug prices and encourage her to support a key Senate bill that would protect Americans from unjustified drug price hikes.
Watch the ad campaign video, “Ashley.”
Currently, the average American pays two to three times more for prescription drugs than citizens in other wealthy countries. The Prescription Drug Pricing Reduction Act of 2019 would curtail runaway price hikes in America and cap out-of-pocket costs for patients on Medicare, who can face more than $15,000 a year in drug costs.
“From leading the FAIR Drug Pricing Act through the HELP committee to speaking out against rising drug prices, we know Senator Murkowski has been standing up to Big Pharma,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “President Trump supports the bipartisan Senate bill, and now we’re asking Senator Murkowski to join in cosponsoring this important legislation. We want her to know that patients will have her back.”
Today’s ads are part of the multi-million dollar campaign Patients For Affordable Drugs Now launched last month that features patients speaking out in support of proposals in the House and Senate to rein in skyrocketing drug prices. The campaign features TV, digital, and radio ads across the country that show the toll high prescription drug prices are taking on everyday Americans. In addition to paid media, the effort features visits from patients to Washington to share their stories in person and gives patients a suite of tools to contact their representatives in support of lowering drug prices.
Big Pharma is spending millions to distort, demonize, and relentlessly attack these proposals because the changes could actually break the rigged system that keeps pharma profits high and patients’ costs skyrocketing.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
BANGOR — Big Pharma is furiously lobbying Washington to protect its profits, but Rep. Jared Golden is fighting for patients as he works to lower drug prices. That’s why today, Patients For Affordable Drugs Now launched a six-figure campaign to thank Rep. Golden for his leadership in the fight to lower drug prices. The average American pays two to three times more for prescription drugs than other wealthy countries.
Watch the ads: “Jackie,” and “Gail.”
Rep. Golden is a cosponsor of H.R. 3 — a bill that would let Medicare negotiate directly with drug companies and make lower prices available to all Americans — regardless of insurance type. The legislation would penalize drug companies if they charge Americans more than they charge in other countries. It would limit drug price increases to the rate of inflation and cap out-of-pocket costs for seniors in Medicare at $2,000 per year. The nonpartisan Congressional Budget Office says the bill would reduce the cost of the most expensive drugs by as much as 55%.
“Mainers are being crushed by high drug prices, and Rep. Golden is fighting back,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “We want to send a message to voters in Maine-02: Big Pharma is spreading scare tactics and lies, but Rep. Golden is standing up for patients.”
As part of the campaign, Patients For Affordable Drugs Now will release a slew of digital ads that show the toll high prescription drug prices are taking on everyday Americans, offer a suite of tools that encourage Americans to contact their representatives in support of lowering drug prices, and share stories of patients suffering under prescription drug prices on social media.
These ads come on the heels of a campaign in August, in which Patients For Affordable Drugs Now thanked GOP Senators who supported the Prescription Drug Pricing Reduction Act of 2019.
Americans overwhelmingly support action to lower drug prices. Eighty-six percent of Americans — majorities of Democrats, Republicans, and Independents — support allowing Medicare to negotiate. Americans pay twice as much for prescription drugs as other nations, and nearly 1 in 3 adults report not taking their medicines as prescribed due to cost.
The mission of Patients For Affordable Drugs Now is to educate the public and mobilize patients to advocate for policies to curb runaway drug prices in America. Touted by The Hill as “a leading drug pricing advocacy group,” Patients For Affordable Drugs Now is a bipartisan non-profit organization established under Section 501(c)(4) of the Internal Revenue Service code. As a 501(c)(4), P4ADNow engages in electoral activity and direct advocacy in support of legislation that would lower drug prices.
###
1. Big Pharma’s Zombie Lies Must Die
2. Get into it
3. Patient voices heard
4. Yes, but
5. The Money Train
Will Washington take a swing at lowering drug prices? Senate, House, and Administration reforms would be a home run for patients.
1. The Plot Thickens
2. A Win for Patients
3. The Legacy of a Hero
4. Taxpayer drug development
5. Big Momentum: